| For: | Testino G, Leone S, Borro P. Alcohol and hepatocellular carcinoma: A review and a point of view. World J Gastroenterol 2014; 20(43): 15943-15954 [PMID: 25473148 DOI: 10.3748/wjg.v20.i43.15943] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i43/15943.htm |
| Number | Citing Articles |
| 1 |
Jalal Poorolajal, Yahya Shadi, Bahram Heshmati. Interaction Between Hepatitis B, Hepatitis C and Alcohol in the Development of Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis. Journal of Viral Hepatitis 2025; 32(1) doi: 10.1111/jvh.14042
|
| 2 |
Tianzuo Zhan, Johannes Betge, Nadine Schulte, Lena Dreikhausen, Michael Hirth, Moying Li, Philip Weidner, Antonia Leipertz, Andreas Teufel, Matthias P. Ebert. Digestive cancers: mechanisms, therapeutics and management. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-024-02097-4
|
| 3 |
Pascal Pineau, Eloy Ruiz, Eric Deharo, Stéphane Bertani. On hepatocellular carcinoma in South America and early-age onset of the disease. Clinics and Research in Hepatology and Gastroenterology 2019; 43(5) doi: 10.1016/j.clinre.2018.10.019
|
| 4 |
Fadi Antaki, Stephanie Judd, Ziad Kanaan, Suhag M. Patel, Kirthi K. Lilley. Textbook of Gastrointestinal Oncology. 2019; doi: 10.1007/978-3-030-18890-0_32
|
| 5 |
Fuat Bicer, Catrina Kure, Anil A. Ozluk, Bassel F. El-Rayes, Mehmet Akce. Advances in Immunotherapy for Hepatocellular Carcinoma (HCC). Current Oncology 2023; 30(11) doi: 10.3390/curroncol30110711
|
| 6 |
Minsuk Cho, Woongchan Rah, Jason Jungsik Song, Yong-Beom Park, Sang-Won Lee. Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index at Diagnosis Is Associated with All-Cause Mortality during Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Medicina 2024; 60(3) doi: 10.3390/medicina60030381
|
| 7 |
Ying Chen, Ming Han, Akiko Matsumoto, Yewei Wang, David C. Thompson, Vasilis Vasiliou. Alcohol and Cancer. Advances in Experimental Medicine and Biology 2018; 1032 doi: 10.1007/978-3-319-98788-0_3
|
| 8 |
Andrei Cosmin Siea, Giulia Collatuzzo, Maha Hamdani, Paolo Boffetta. Welding Fumes Exposure and the Risk of Head and Neck and Gastrointestinal Cancer: A Systematic Review and Meta-Analysis. La Medicina del Lavoro 2025; 116(2) doi: 10.23749/mdl.v116i2.16092
|
| 9 |
Su-Chen Lan, Yueh-E Lin, Shu-Ching Chen, Yu-Fang Lin, Yu-Jen Wang. Effects of Acupressure on Fatigue and Depression in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Quasi-Experimental Study. Evidence-Based Complementary and Alternative Medicine 2015; 2015 doi: 10.1155/2015/496485
|
| 10 |
Gianni Testino, Silvia Leone, Paolo Borro. Antiviral therapy and hepatocellular carcinogenesis. Cancer 2016; 122(1) doi: 10.1002/cncr.29696
|
| 11 |
Perttu Sahlman, Markku Nissinen, Eero Pukkala, Martti Färkkilä. Cancer incidence among alcoholic liver disease patients in Finland: A retrospective registry study during years 1996–2013. International Journal of Cancer 2016; 138(11) doi: 10.1002/ijc.29995
|
| 12 |
Derek J. Erstad, Allen A. Razavi, Shen Li, Kenneth K. Tanabe, Bryan C. Fuchs. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; doi: 10.1007/978-3-030-21540-8_13
|
| 13 |
Nisha Sahu, Samrat Rakshit, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; doi: 10.1016/B978-0-323-98806-3.00023-4
|
| 14 |
. 2019; doi: 10.70675/f5028a6dz55e9z4066zb918z9ffcc4b218b4
|
| 15 |
Gianvito Candita, Sara Rossi, Karolina Cwiklinska, Salvatore Claudio Fanni, Dania Cioni, Riccardo Lencioni, Emanuele Neri. Imaging Diagnosis of Hepatocellular Carcinoma: A State-of-the-Art Review. Diagnostics 2023; 13(4) doi: 10.3390/diagnostics13040625
|
| 16 |
Lu Wang, Zigong Shao, Xiaobei Wang, Wenqiu Lu, Hong Sun. Xenobiotic-induced liver injury: Molecular mechanisms and disease progression. Ecotoxicology and Environmental Safety 2025; 303 doi: 10.1016/j.ecoenv.2025.118854
|
| 17 |
|
| 18 |
Elin Storjord, Jim A. Dahl, Anne Landsem, Judith K. Ludviksen, Marlene B. Karlsen, Bård O. Karlsen, Ole-L. Brekke. Lifestyle factors including diet and biochemical biomarkers in acute intermittent porphyria: Results from a case-control study in northern Norway. Molecular Genetics and Metabolism 2019; 128(3) doi: 10.1016/j.ymgme.2018.12.006
|
| 19 |
Kai Zhang, Anna E. Barry, Ryan Lamm, Keyur Patel, Michelle Schafer, Hien Dang. The role of RNA binding proteins in hepatocellular carcinoma. Advanced Drug Delivery Reviews 2022; 182 doi: 10.1016/j.addr.2022.114114
|
| 20 |
Subhas Das, Soumyabrata Chatterjee, Tushar Patel, Soma Banerjee. RNA renaissance: Harnessing non-coding RNA therapeutics for hepatocellular carcinoma. Pharmacology & Therapeutics 2026; 277 doi: 10.1016/j.pharmthera.2025.108956
|
| 21 |
John C. McVey, Qianfei Zhang, Tim F. Greten, Chi Ma. Inflammation, Infection, and Microbiome in Cancers. Physiology in Health and Disease 2021; doi: 10.1007/978-3-030-67951-4_7
|
| 22 |
Gennaro D'Amico, Ramon Bataller. Need for surveillance of hepatocellular carcinoma in patients with alcoholic cirrhosis. Journal of Hepatology 2018; 69(6) doi: 10.1016/j.jhep.2018.09.027
|
| 23 |
Yu Asari, Jumpei Yamazaki, Oo Thandar, Tamami Suzuki, Keisuke Aoshima, Kyosuke Takeuchi, Ryohei Kinoshita, Sangho Kim, Kenji Hosoya, Teita Ishizaki, Yumiko Kagawa, Jaroslav Jelinek, Shoko Yokoyama, Noboru Sasaki, Hiroshi Ohta, Kensuke Nakamura, Mitsuyoshi Takiguchi. Diverse genome‐wide DNA methylation alterations in canine hepatocellular tumours. Veterinary Medicine and Science 2023; 9(5) doi: 10.1002/vms3.1204
|
| 24 |
|
| 25 |
Nur Signa Aini Gumilas, Irianiwati Widodo, Neneng Ratnasari, Didik Setyo Heriyanto. Potential relative quantities of miR-122 and miR-150 to differentiate hepatocellular carcinoma from liver cirrhosis. Non-coding RNA Research 2022; 7(1) doi: 10.1016/j.ncrna.2022.01.004
|
| 26 |
Elijah Ige Ohimain. Methanol contamination in traditionally fermented alcoholic beverages: the microbial dimension. SpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-3303-1
|
| 27 |
Takefumi Kimura, Naoki Tanaka, Naoyuki Fujimori, Ayumi Sugiura, Tomoo Yamazaki, Satoru Joshita, Michiharu Komatsu, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka. Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis. World Journal of Gastroenterology 2018; 24(13): 1440-1450 doi: 10.3748/wjg.v24.i13.1440
|
| 28 |
Animal Models of Disease - Part A. Methods in Cell Biology 2024; 185 doi: 10.1016/bs.mcb.2024.02.006
|
| 29 |
Yiwen Zhang, Bingfang Hu, Shaoxing Guan, Pan Li, Yingjie Guo, Pengfei Xu, Yongdong Niu, Yujin Li, Ye Feng, Jiewen Du, Jun Xu, Xiuchen Guan, Jingkai Gu, Haiyan Sun, Min Huang. Activation of pregnane X receptor sensitizes alcoholic steatohepatitis by transactivating fatty acid binding protein 4. Acta Pharmaceutica Sinica B 2024; 14(11) doi: 10.1016/j.apsb.2024.08.029
|
| 30 |
Frederik Nikolai Schulz, Alexander A. Kugel, Jon H. Hanf. Balancing Gains and Losses—A Research Note on Tradeoffs in the Case of Non-Alcoholic Wines in Germany. Sustainability 2024; 16(6) doi: 10.3390/su16062451
|
| 31 |
H. Taflin, L. Hafström, E. Holmberg, M. Castedal, P. Lindnér. The impact of increased immigration to Sweden on the incidence and treatment of patients with HCC and underlying liver disease. Scandinavian Journal of Gastroenterology 2019; 54(6) doi: 10.1080/00365521.2019.1627580
|
| 32 |
Gianni TESTINO, Rinaldo PELLICANO. Metabolic associated liver disease. Panminerva Medica 2022; 64(4) doi: 10.23736/S0031-0808.22.04730-9
|
| 33 |
Won Keun Si, Jung Wha Chung, Junhyeon Cho, Joo Yeong Baeg, Eun Sun Jang, Hyuk Yoon, Jaihwan Kim, Cheol Min Shin, Young Soo Park, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee, Soo Lim, Jin-Wook Kim, Motoyuki Otsuka. Predictors of Increased Risk of Hepatocellular Carcinoma in Patients with Type 2 Diabetes. PLOS ONE 2016; 11(6) doi: 10.1371/journal.pone.0158066
|
| 34 |
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations. Journal of Clinical and Experimental Hepatology 2020; 10(1) doi: 10.1016/j.jceh.2019.09.007
|
| 35 |
Varimadugu Aruna, A. Sneha, D. Sai Harshitha. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; doi: 10.1016/B978-0-323-98806-3.00022-2
|
| 36 |
Hiroshi Matsushita, Akinobu Takaki. Alcohol and hepatocellular carcinoma. BMJ Open Gastroenterology 2019; 6(1) doi: 10.1136/bmjgast-2018-000260
|
| 37 |
Hepatobiliary Cancers: Translational Advances and Molecular Medicine. Advances in Cancer Research 2022; 156 doi: 10.1016/bs.acr.2022.01.006
|
| 38 |
Paolo BORRO, Gianni TESTINO, Rinaldo PELLICANO, Fabio CAPUTO. Early detection of hepatocellular carcinoma in alcoholic liver disease. Panminerva Medica 2021; 63(4) doi: 10.23736/S0031-0808.19.03763-7
|
| 39 |
Jongbeom Shin, Jung Hwan Yu, Young-Joo Jin, Myoung Hun Chae, Chang Hwi Yoon, Jin-Woo Lee. Comparison of survival outcomes of alcohol-related hepatocellular carcinoma with or without liver cirrhosis; a ten-year experience. Medicine 2019; 98(47) doi: 10.1097/MD.0000000000018020
|
| 40 |
Lauren S. Strathearn, Afanasii I. Stepanov, Joan Font-Burgada. Inflammation in Primary and Metastatic Liver Tumorigenesis–Under the Influence of Alcohol and High-Fat Diets. Nutrients 2020; 12(4) doi: 10.3390/nu12040933
|
| 41 |
Noor Atika Azit, Shahnorbanun Sahran, Leow Voon Meng, Manisekar Subramaniam, Suryati Mokhtar, Azmawati Mohammed Nawi, Yun-Wen Zheng. Risk factors of hepatocellular carcinoma in type 2 diabetes patients: A two-centre study in a developing country. PLOS ONE 2021; 16(12) doi: 10.1371/journal.pone.0260675
|
| 42 |
Hossein Miri, Payman Rahimzadeh, Mehrdad Hashemi, Noushin Nabavi, Amir Reza Aref, Salman Daneshi, Alireza Razzaghi, Maryam Abedi, Safa Tahmasebi, Najma Farahani, Afshin Taheriazam. Harnessing immunotherapy for hepatocellular carcinoma: Principles and emerging promises. Pathology - Research and Practice 2025; 269 doi: 10.1016/j.prp.2025.155928
|
| 43 |
Shen Li, Antonio Saviano, Derek J. Erstad, Yujin Hoshida, Bryan C. Fuchs, Thomas Baumert, Kenneth K. Tanabe. Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges. Journal of Clinical Medicine 2020; 9(12) doi: 10.3390/jcm9123817
|
| 44 |
Diski Saisa, Syifa Mustika, Mochamad Fachrureza, Stevanus Christian Surya, Derren Rampengan, Juan Alessandro Jeremis Maruli Nura Lele, Ammar Nojaid, Michael Owen Hogipranata. Effect of statin use on prognostic outcomes in hepatocellular carcinoma following liver surgery: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2026; 38(5) doi: 10.1097/MEG.0000000000003110
|
| 45 |
Yue Jia, Ping Ji, Samuel W. French. The Role of FAT10 in Alcoholic Hepatitis Pathogenesis. Biomedicines 2020; 8(7) doi: 10.3390/biomedicines8070189
|
| 46 |
Elisabeth Digifico, Silvia Balinzo, Cristina Belgiovine. The Dark Side of the Force: When the Immune System Is the Fuel of Tumor Onset. International Journal of Molecular Sciences 2021; 22(3) doi: 10.3390/ijms22031224
|
| 47 |
G. Testino, S. Leone. Chemoprevention of hepatocellular carcinoma in people affected by hepatitis C virus: what changes does the introduction of direct-acting antiviral agents make?. Annals of Oncology 2016; 27(10) doi: 10.1093/annonc/mdw257
|
| 48 |
. 2020; doi: 10.70675/5de6407cz6b7fz41b5zb238zbc2aed4bbd14
|
| 49 |
Mengna Wu, Huajie Miao, Rong Fu, Jie Zhang, Wenjie Zheng . Hepatic Stellate Cell: A Potential Target for Hepatocellular Carcinoma. Current Molecular Pharmacology 2020; 13(4) doi: 10.2174/1874467213666200224102820
|
| 50 |
Satoshi SEINO. Function of Orally Ingested Acetic Acid Bacteria: Contribution to Responsible Drinking. JOURNAL OF THE BREWING SOCIETY OF JAPAN 2020; 115(2) doi: 10.6013/jbrewsocjapan.115.85
|
| 51 |
Marianna V. Papageorge, Alison P. Woods, Susanna W.L. de Geus, Sing Chau Ng, Michael K. Paasche-Orlow, Dorry Segev, David McAneny, Kelly M. Kenzik, Teviah E. Sachs, Jennifer F. Tseng. Beyond insurance status: the impact of Medicaid expansion on the diagnosis of Hepatocellular Carcinoma. HPB 2022; 24(8) doi: 10.1016/j.hpb.2021.12.020
|
| 52 |
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes. Cancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
|
| 53 |
Qian-Qian Shao, Bang-Bo Zhao, Liang-Bo Dong, Hong-Tao Cao, Wei-Bin Wang. Surgical management of Zollinger-Ellison syndrome: Classical considerations and current controversies. World Journal of Gastroenterology 2019; 25(32): 4673-4681 doi: 10.3748/wjg.v25.i32.4673
|
| 54 |
Sathishbabu Paranthaman, Umme Hani, Riyaz Ali M. Osmani, Rohit R. Bhosale, Nazima Haider. Current advances in nanoparticle-based approaches for the hepatocellular carcinoma treatment. Clinics and Research in Hepatology and Gastroenterology 2025; 49(1) doi: 10.1016/j.clinre.2024.102508
|
| 55 |
Urmimala Chaudhuri, Chase T Thornton, Timothy N Crawford, Drew Triplett. Trends in Incidence of Hepatocellular Carcinoma Between 2000 and 2020: A Surveillance, Epidemiology, and End Results (SEER)-Based Analysis. Cureus 2025; doi: 10.7759/cureus.84487
|
| 56 |
Juncheng Wei, Deyu Fang. Endoplasmic Reticulum Stress Signaling and the Pathogenesis of Hepatocarcinoma. International Journal of Molecular Sciences 2021; 22(4) doi: 10.3390/ijms22041799
|
| 57 |
Dávid Líška. Physical activity and hepatocellular carcinoma: A narrative review. Slovak Journal of Sport Science 2026; 11(1) doi: 10.24040/sjss.2026.11.1.74-98
|
| 58 |
Linda Galasso, Lucia Cerrito, Valeria Maccauro, Fabrizio Termite, Irene Mignini, Giorgio Esposto, Raffaele Borriello, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco. Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon. International Journal of Molecular Sciences 2024; 25(13) doi: 10.3390/ijms25137191
|
| 59 |
Ashakumary Lakshmikuttyamma, Abigail Kay. A worldwide yearly survey of new data in adverse drug reactions. Side Effects of Drugs Annual 2015; 37 doi: 10.1016/bs.seda.2015.08.001
|
| 60 |
Yue Jia, Ping Ji, Barbara French, Brittany Tillman, Samuel W. French. The different expression of tumor suppressors, RASSF1A, RUNX3, and GSTP1, in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH). Experimental and Molecular Pathology 2019; 108 doi: 10.1016/j.yexmp.2019.04.002
|
| 61 |
S Dahlberg, U Schött. Vitamin K: A potential Liver Cancer treatment way. Archives of Hepatitis Research 2017; 3(1) doi: 10.17352/ahr.000017
|
| 62 |
Xiaoqing Jia, Rong Li, Xiaoting Zhang, Tao Zhou, Dalong Sun, Na Yang, Zheng Luo. Increased age, bilirubin, international normalized ratio, and creatinine score to triglyceride ratio are associated with alcohol-associated primary liver carcinoma: a single-centered retrospective study. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01888-y
|
| 63 |
Kerstin Schütte, Fathi Balbisi, Peter Malfertheiner. Prevention of Hepatocellular Carcinoma. Gastrointestinal Tumors 2016; 3(1) doi: 10.1159/000446680
|
| 64 |
Murali Ganesan, Allison Eikenberry, Larisa Y Poluektova, Kusum K Kharbanda, Natalia A Osna. Role of alcohol in pathogenesis of hepatitis B virus infection. World Journal of Gastroenterology 2020; 26(9): 883-903 doi: 10.3748/wjg.v26.i9.883
|
| 65 |
Yogambigai Rajamoorthy, Niazlin Mohd Taib, Mudatsir Mudatsir, Harapan Harapan, Abram Luther Wagner, Subramaniam Munusamy, Khalid Abdul Rahim, Alias Radam. Risk behaviours related to hepatitis B virus infection among adults in Malaysia: A cross-sectional household survey. Clinical Epidemiology and Global Health 2020; 8(1) doi: 10.1016/j.cegh.2019.04.011
|
| 66 |
Luan Nguyen, Myrthe Jager, Ruby Lieshout, Petra E. de Ruiter, Mauro D. Locati, Nicolle Besselink, Bastiaan van der Roest, Roel Janssen, Sander Boymans, Jeroen de Jonge, Jan N. M. IJzermans, Michail Doukas, Monique M. A. Verstegen, Ruben van Boxtel, Luc J. W. van der Laan, Edwin Cuppen, Ewart Kuijk. Precancerous liver diseases do not cause increased mutagenesis in liver stem cells. Communications Biology 2021; 4(1) doi: 10.1038/s42003-021-02839-y
|
| 67 |
Monica Leon, Joseph Varon, Salim Surani. When a liver transplant recipient goes back to alcohol abuse: Should we be more selective?. World Journal of Gastroenterology 2016; 22(20): 4789-4793 doi: 10.3748/wjg.v22.i20.4789
|
| 68 |
Lancharat Chuncharunee, Noriyo Yamashiki, Ammarin Thakkinstian, Abhasnee Sobhonslidsuk. Alcohol relapse and its predictors after liver transplantation for alcoholic liver disease: a systematic review and meta-analysis. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1050-9
|
| 69 |
Rup Kumar Phukan, Biswa Jyoti Borkakoty, Sanjib Kumar Phukan, Kumar Bhandari, Jagdish Mahanta, Sopai Tawsik, Sangita Bhandari, Ashish Rai, Kanwar Narain. Association of processed food, synergistic effect of alcohol and HBV with Hepatocellular Carcinoma in a high incidence region of India. Cancer Epidemiology 2018; 53 doi: 10.1016/j.canep.2018.01.005
|
| 70 |
Mohamed M. Makhlouf, Mohamed Abdel Mabood, Shereen A. Saleh, Sarah El Nakeep, Sara M. Abdelhakam, Marwa Rushdy, Essam M. Abd-Al Hafez, Ahmed Abbas. Serum Golgi protein-73 in combination with α-fetoprotein for diagnosing hepatocellular carcinoma in Egyptian patients. The Egyptian Journal of Internal Medicine 2017; 29(2) doi: 10.4103/ejim.ejim_4_17
|
| 71 |
Selina Becht, Najib Ben Khaled, Simone Schrodi, Michael von Bergwelt-Baildon, Peter Buggisch, Alexander Crispin, Wolf-Peter Hofmann, Ursula Marschall, Julia Mayerle, Bernhard Mörtl, Sami Orabi, Alexander Philipp, Jörg Trojan, Tobias Weiglein, Enrico N. De Toni, Karin Berger-Thürmel. What can claims data tell us about risk factors and survival of patients with hepatocellular carcinoma? Insights from a German population-based study. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1650982
|
| 72 |
Yaojie Fu, Luca Maccioni, Xin Wei Wang, Tim F. Greten, Bin Gao. Alcohol-associated liver cancer. Hepatology 2024; 80(6) doi: 10.1097/HEP.0000000000000890
|
| 73 |
Maria Eduarda Lopes Baitello, Graciele Domitila Tenani, Rafael Fernandes Ferreira, Victor Nogueira, Marcela Augusta de Souza Pinhel, Rita de Cássia Martins Alves da Silva, Renato Ferreira da Silva, Patrícia da Silva Fucuta, Moacir Fernandes de Godoy, Dorotéia Rossi Silva Souza. VEGF Polymorphisms Related to Higher Serum Levels of Protein Identify Patients with Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2016; 2016 doi: 10.1155/2016/9607054
|
| 74 |
Vinícius Barreto Garcia, Thaís Gomes de Carvalho, Luiz Henrique da Silva Gasparotto, Heloiza Fernanda Oliveira da Silva, Aurigena Antunes de Araújo, Gerlane Coelho Bernardo Guerra, Timo Schomann, Luis J. Cruz, Alan B. Chan, Raimundo Fernandes de Araújo Júnior. Environmentally compatible bioconjugated gold nanoparticles as efficient contrast agents for inflammation-induced cancer imaging. Nanoscale Research Letters 2019; 14(1) doi: 10.1186/s11671-019-2986-y
|
| 75 |
Nada Assi, Marc J Gunter, Duncan C Thomas, Michael Leitzmann, Magdalena Stepien, Véronique Chajès, Thierry Philip, Paolo Vineis, Christina Bamia, Marie-Christine Boutron-Ruault, Torkjel M Sandanger, Amaia Molinuevo, Hendriek Boshuizen, Anneli Sundkvist, Tilman Kühn, Ruth Travis, Kim Overvad, Elio Riboli, Augustin Scalbert, Mazda Jenab, Vivian Viallon, Pietro Ferrari. Metabolic signature of healthy lifestyle and its relation with risk of hepatocellular carcinoma in a large European cohort. The American Journal of Clinical Nutrition 2018; 108(1) doi: 10.1093/ajcn/nqy074
|
| 76 |
Gianni TESTINO, Sharmila FAGOONEE, Fabio CAPUTO, Rinaldo PELLICANO. The early identification of alcohol use disorders and liver injury: proposal for a diagnostic algorithm. Panminerva Medica 2021; 63(3) doi: 10.23736/S0031-0808.21.04272-5
|
| 77 |
Kim B Pedersen, Casey F Pulliam, Aarshvi Patel, Fabio Del Piero, Tatiane T N Watanabe, Umesh D Wankhade, Kartik Shankar, Chindo Hicks, Martin J Ronis. Liver tumorigenesis is promoted by a high saturated fat diet specifically in male mice and is associated with hepatic expression of the proto-oncogene Agap2 and enrichment of the intestinal microbiome with Coprococcus. Carcinogenesis 2019; 40(2) doi: 10.1093/carcin/bgy141
|
| 78 |
Luana Vittoria Bauso, Valeria La Fauci, Serena Munaò, Desirèe Bonfiglio, Alessandra Armeli, Noemi Maimone, Clelia Longo, Giovanna Calabrese. Biological Activity of Natural and Synthetic Peptides as Anticancer Agents. International Journal of Molecular Sciences 2024; 25(13) doi: 10.3390/ijms25137264
|
| 79 |
. 2024; doi: 10.70675/17f40991z07caz494dz92c1zb35a1113a4e7
|
| 80 |
Ran-Xu Zhu, Alfred Sze Lok Cheng, Henry Lik Yuen Chan, Dong-Ye Yang, Wai-Kay Seto. Growth arrest-specific gene 2 suppresses hepatocarcinogenesis by intervention of cell cycle and p53-dependent apoptosis. World Journal of Gastroenterology 2019; 25(32): 4715-4726 doi: 10.3748/wjg.v25.i32.4715
|
| 81 |
Luis Calzadilla Bertot, Leon A Adams. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2019; 13(2) doi: 10.1080/17474124.2019.1549989
|
| 82 |
Aakash Desai, Sonia Sandhu, Jin-Ping Lai, Dalbir Singh Sandhu. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World Journal of Hepatology 2019; 11(1): 1-18 doi: 10.4254/wjh.v11.i1.1
|
| 83 |
Lais Yuki Tuzino Kamia, Emily Gonzalez, Cassandra M. Swanson, Stephanie L. Gomez, Ariann M. Canales, Ramona Salcedo Price. Risk Factors for Hepatocellular Carcinoma in Latino Populations in Texas: A Scoping Review. International Journal of Molecular Sciences 2026; 27(10) doi: 10.3390/ijms27104648
|
| 84 |
Edward Andrew Mead, Yongping Wang, Sunali Patel, Austin P. Thekkumthala, Rebecca Kepich, Elizabeth Benn-Hirsch, Victoria Lee, Azra Basaly, Susan Bergeson, Hava T. Siegelmann, Andrzej Zbigniew Pietrzykowski. miR-9 utilizes precursor pathways in adaptation to alcohol in mouse striatal neurons. Advances in Drug and Alcohol Research 2023; 3 doi: 10.3389/adar.2023.11323
|
| 85 |
Gianni TESTINO, Carmen FUCILE, Maurizia GNOCCHI, Gian M. ROSA, Fabio CAPUTO. Steatotic liver disease: what role does alcohol consumption play?. Minerva Medica 2025; 116(5) doi: 10.23736/S0026-4806.25.09726-5
|
| 86 |
Stefan G. Hübscher. Practical Hepatic Pathology: a Diagnostic Approach. 2018; doi: 10.1016/B978-0-323-42873-6.00024-X
|
| 87 |
Wenying Qiao, Shugui Sheng, Junnan Li, Ronghua Jin, Caixia Hu. Machine Learning-Based Nomogram for Predicting Overall Survival in Elderly Patients with Cirrhotic Hepatocellular Carcinoma Undergoing Ablation Therapy. Journal of Hepatocellular Carcinoma 2024; doi: 10.2147/JHC.S450825
|
| 88 |
Gianni Testino, Emanuele Scafato, Valentino Patussi, Patrizia Balbinot, Andrea Ghiselli, Fabio Caputo. Alcohol and cancer: a denied association the statement of the Italian society on alcohol (Società Italiana di Alcologia—SIA). Alcohol and Alcoholism 2023; 58(6) doi: 10.1093/alcalc/agad064
|
| 89 |
Wei Wang, Shilin-L. Tian, Hui Wang, Chun-Chun Shao, Yong-Zheng Wang, Yu-Liang Li. Association of Hepatitis B Virus DNA Level and Follow-up Interval With Hepatocellular Carcinoma Recurrence. JAMA Network Open 2020; 3(4) doi: 10.1001/jamanetworkopen.2020.3707
|
| 90 |
Mohamed Mourad, Fanny Lebossé, Philippe Merle, Massimo Levrero, Teresa Antonini, Mickaël Lesurtel, Christian Ducerf, Fabien Zoulim, Jean‐Yves Mabrut, Kayvan Mohkam. External validation of the French alpha‐fetoprotein model for hepatocellular carcinoma liver transplantation in a recent unicentric cohort – a retrospective study. Transplant International 2021; 34(3) doi: 10.1111/tri.13819
|
| 91 |
Silvia Andaloro, Fabrizio Mancuso, Luca Miele, Giovanni Addolorato, Antonio Gasbarrini, Francesca Romana Ponziani. Effect of Low-Dose Alcohol Consumption on Chronic Liver Disease. Nutrients 2024; 16(5) doi: 10.3390/nu16050613
|
| 92 |
|
| 93 |
Rolf Teschke. Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects. Biomedicines 2018; 6(4) doi: 10.3390/biomedicines6040106
|
| 94 |
Yang Luo, Yue Zhang, Di Wang, Di Shen, Yi-Qun Che. <p>Eradication of Hepatitis C Virus (HCV) Improves Survival of Hepatocellular Carcinoma Patients with Active HCV Infection – A Real-World Cohort Study</p>. Cancer Management and Research 2020; doi: 10.2147/CMAR.S254580
|
| 95 |
Kazuo Tarao, Akito Nozaki, Takaaki Ikeda, Akira Sato, Hirokazu Komatsu, Tatsuji Komatsu, Masataka Taguri, Katsuaki Tanaka. Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment. Cancer Medicine 2019; 8(3) doi: 10.1002/cam4.1998
|
| 96 |
Makiko Taniai. Alcohol and hepatocarcinogenesis. Clinical and Molecular Hepatology 2020; 26(4) doi: 10.3350/cmh.2020.0203
|
| 97 |
Jinying Peng, Gaoshuang Liang, Yaqi Li, Siyu Mao, Chen Zhang, Ying Wang, Zhuan Li. Identification of a novel FOXO3 agonist that protects against alcohol induced liver injury. Biochemical and Biophysical Research Communications 2024; 704 doi: 10.1016/j.bbrc.2024.149690
|
| 98 |
Xia Cui, Qingyan Li, Yukai He. miR-3117 regulates hepatocellular carcinoma cell proliferation by targeting PHLPPL. Molecular and Cellular Biochemistry 2017; 424(1-2) doi: 10.1007/s11010-016-2855-2
|
| 99 |
. 2021; doi: 10.70675/89a283f4z65c6z4519z9345z6a5c0c0a72ec
|
| 100 |
Eric Siskind, Rolf N. Barth. Disease Recurrence After Liver Transplantation. 2016; doi: 10.1007/978-1-4939-2947-4_7
|
| 101 |
Gyongyi Szabo. Alcohol and Cancer. Advances in Experimental Medicine and Biology 2018; 1032 doi: 10.1007/978-3-319-98788-0_5
|
| 102 |
Yang-Hsiang Lin, Meng-Han Wu, Ya-Hui Huang, Chau-Ting Yeh, Kwang-Huei Lin. TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma. Cells 2020; 9(2) doi: 10.3390/cells9020262
|
| 103 |
Wasit Wongtrakul, Sorachat Niltwat, Phunchai Charatcharoenwitthaya. The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.744713
|
| 104 |
Marwa Shouman, Ayad A. Jaffa, Miran A. Jaffa. The impact of diabetes and social, biologic and behavioral determinants of health on liver cancer risk. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1562854
|
| 105 |
Mifleh Tatour, Fadi Abu Baker, Tarek Saadi, Ahmad Yahia, Rawi Hazzan. Advancements in autoimmune hepatitis epidemiology, treatment and complication – a 15-year retrospective study. Clinics and Research in Hepatology and Gastroenterology 2025; 49(4) doi: 10.1016/j.clinre.2025.102570
|
| 106 |
Yvonne Huber, Franziska Bierling, Christian Labenz, Sandra Koch, Irene Schmidtmann, Roman Kloeckner, Sebastian Schotten, Tobias Huber, Hauke Lang, Marcus A. Woerns, Peter R. Galle, Arndt Weinmann, Julia Weinmann-Menke. Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4677-y
|
| 107 |
Kang Zheng, Francisco Cubero, Yulia Nevzorova. c-MYC—Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease. Genes 2017; 8(4) doi: 10.3390/genes8040123
|
| 108 |
Sim Ming Ann, Glenn Kunnath Bonney, Ashokka Balakrishnan. Prehabilitation for Cancer Surgery. 2022; doi: 10.1007/978-981-16-6494-6_11
|
| 109 |
Yue Jia, Barbara French, Brittany Tillman, Samuel French. Different roles of FAT10, FOXO1, and ADRA2A in hepatocellular carcinoma tumorigenesis in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH). Experimental and Molecular Pathology 2018; 105(1) doi: 10.1016/j.yexmp.2018.07.005
|
| 110 |
Irfan A. Kazi, Vinay Jahagirdar, Bareen W. Kabir, Almaan K. Syed, Asad W. Kabir, Abhilash Perisetti. Role of Imaging in Screening for Hepatocellular Carcinoma. Cancers 2024; 16(19) doi: 10.3390/cancers16193400
|
| 111 |
Ron C. Gaba, Nasya Mendoza-Elias, Daniel P. Regan, Kelly D. Garcia, R. Peter Lokken, Regina M. Schwind, Michael Eichner, Faith M. Thomas, Lauretta A. Rund, Lawrence B. Schook, Kyle M. Schachtschneider. Characterization of an Inducible Alcoholic Liver Fibrosis Model for Hepatocellular Carcinoma Investigation in a Transgenic Porcine Tumorigenic Platform. Journal of Vascular and Interventional Radiology 2018; 29(8) doi: 10.1016/j.jvir.2018.03.007
|
| 112 |
Gianni Testino. Early detection of alcoholic liver disease. Scandinavian Journal of Gastroenterology 2016; 51(11) doi: 10.1080/00365521.2016.1199732
|
| 113 |
Xiangye Liu, Tingting Li, Delong Kong, Hongjuan You, Fanyun Kong, Renxian Tang. Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07689-1
|
| 114 |
Adeola D. Ayanyinka, Itunuoluwa C. Oyelayo, Habeeb O. Abiona, Fiyinfoluwa Demilade Ojeniyi, Oluyinka O. Opaleye, Olusola Ojurongbe, Olugbenga A. Olowe. Prevalence of hepatitis B virus infection among individuals with active tuberculosis attending selected Directly Observed Therapy (DOT) clinics in Oyo State, Nigeria. BMC Infectious Diseases 2025; 25(1) doi: 10.1186/s12879-025-12171-z
|
| 115 |
Mohammad R. Salmanpour, Seyed Mohammad Piri, Somayeh Sadat Mehrnia, Ahmad Shariftabrizi, Masume Allahmoradi, Venkata SK. Manem, Arman Rahmim, Ilker Hacihaliloglu. Pathobiological Dictionary Defining Pathomics and Texture Features: Addressing Understandable AI Issues in Personalized Liver Cancer; Dictionary Version LCP1.0. Journal of Imaging Informatics in Medicine 2026; doi: 10.1007/s10278-025-01817-8
|
| 116 |
Nada Assi, Duncan C. Thomas, Michael Leitzmann, Magdalena Stepien, Véronique Chajès, Thierry Philip, Paolo Vineis, Christina Bamia, Marie-Christine Boutron-Ruault, Torkjel M. Sandanger, Amaia Molinuevo, Hendriek C. Boshuizen, Anneli Sundkvist, Tilman Kühn, Ruth C. Travis, Kim Overvad, Elio Riboli, Marc J. Gunter, Augustin Scalbert, Mazda Jenab, Pietro Ferrari, Vivian Viallon. Are Metabolic Signatures Mediating the Relationship between Lifestyle Factors and Hepatocellular Carcinoma Risk? Results from a Nested Case–Control Study in EPIC. Cancer Epidemiology, Biomarkers & Prevention 2018; 27(5) doi: 10.1158/1055-9965.EPI-17-0649
|
| 117 |
Gianni TESTINO, Rinaldo PELLICANO. Corrected and republished from: Metabolic associated liver disease. Panminerva Medica 2023; 65(3) doi: 10.23736/S0031-0808.23.04850-4
|
| 118 |
Michael Karin, Ju Youn Kim. MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives. Molecular Oncology 2025; 19(2) doi: 10.1002/1878-0261.13685
|